Public deliverables

Pancreatic cancer early detection • multiplex immunoassays • heritable genetic risk • cancer screening • 

This page will give you the opportunity to download all the public deliverables of the project, once submitted.

#NameMonth
D1.1Data Management PlanMonth 6 (October 2025)
D1.2Updated Data Management PlanMonth 36 (April 2028)
D1.3Risk Management & Quality Assurance PlanMonth 12 (April 2026)
D2.1SHIELD Requirement ReportMonth 12 (April 2026)
D2.2Data Security, Accessibility, and Regulatory planMonth 24 (April 2027)
D2.3Legal and Ethical frameworkMonth 24 (April 2027)
D3.1Interactive citizen recruitment interfaceMonth 18 (October 2026)
D3.4Language management reportMonth 18 (October 2026)
D4.1Identification strategy reportMonth 24 (April 2027)
D4.2Genetic testingMonth 36 (April 2028)
D4.3Surveillance program interim reportMonth 24 (April 2027)
D4.4Surveillance program final reportMonth 48 (April 2029)
D4.5Clinical study initiation packageMonth 9 (January 2026)
D4.6Clinical study interim recruitment reportMonth 28 (August 2027)
D4.7Clinical study final reportMonth 48 (April 2029)
D5.2Sample analysis reportMonth 42 (October 2028)
D5.3Clinical validation reportMonth 48 (April 2029)
D5.5Risk factor reportMonth 48 (April 2029)
D6.1Outreach and engagement strategy and planMonth 6 (October 2025)
D6.2Outreach and engagement interim reportMonth 24 (April 2027)
D6.3HTA report Health Technology Assessment ResultsMonth 46 (February 2029)
D6.4PDAC surveillance guidelinesMonth 48 (April 2029)
D6.6Outreach and engagement final reportMonth 48 (April 2029)
D6.7Upscaling report Actions for integration with programmesMonth 48 (April 2029)